6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0111 770-25-2-801-0179 -National CMOP S0174 SUMATRIPTAN 6MG
ID: 36C77025Q0111Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/6e5c0e0993864d57b7a2bfd2c3279489/view
Timeline
    Description

    The Department of Veterans Affairs is seeking bids for an emergency procurement of Sumatriptan 6MG Injection Syringes, as outlined in solicitation number 36C77025Q0111. This procurement involves multiple quantities of the pharmaceutical product, which will be delivered to various Consolidated Mail Outpatient Pharmacy (CMOP) facilities across the United States. The solicitation is unrestricted, with a preference for U.S.-made products, and requires vendors to submit comprehensive quotes, including an Excel price schedule and proof of state wholesale distributor licensure, in compliance with the Drug Supply Chain Security Act. Interested vendors must submit their quotes electronically to Contract Specialist Michael W. McAlhaney by January 14, 2025, at 9:00 AM CST, with an estimated award date of January 17, 2025.

    Point(s) of Contact
    Michael W McAlhaneyContracting Specialist
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0111_1.docx
    The document outlines a solicitation for pharmaceutical supplies by the Department of Veterans Affairs (VA) through Contracting Office NCO 15. The purpose is to procure specific medications, including Sumatriptan injections, along with requirements for delivery and compliance with health and safety regulations. The solicitation emphasizes deadlines for quotations, mandates the inclusion of necessary documentation, such as a State Wholesale Distributor License, and outlines shipping and invoicing instructions. The contract stipulates compliance with the Drug Supply Chain Security Act (DSCSA), including providing transaction histories and statements. Furthermore, it details requirements for barcoding, therapeutic equivalence, recalls, and invoicing procedures, stressing the importance of adherence to federal regulations. Vendor responsibilities are highlighted, including maintaining pharmaceutical product suitability, labeling requirements, and payment submission. The document serves as a formal request for proposals (RFP) from eligible contractors to ensure the VA’s needs for pharmaceutical products are met efficiently while complying with applicable legal standards.
    36C77025Q0111.docx
    The Department of Veterans Affairs is soliciting bids for an emergency procurement of Sumatriptan 6MG Injection Syringes. The solicitation, numbered 36C77025Q0111, is set to be open for responses until January 14, 2025, at 9:00 AM CST, with an estimated award date of January 17, 2025. This requirement involves multiple quantities of the pharmaceutical, to be delivered across various CMOP facilities in the U.S. Vendors must provide comprehensive quotes including an Excel price schedule, proof of state wholesale distributor licensure, and meet compliance with the Drug Supply Chain Security Act. The solicitation is deemed unrestricted, and U.S.-made products are preferred, in line with the World Trade Organization Government Procurement Agreement. Responses must be submitted electronically to the designated Contract Specialist, Michael W. McAlhaney. It is the vendors' responsibility to monitor changes on the Contract Opportunities website (sam.gov). The document emphasizes the importance of fulfilling all stated requirements to avoid technical disqualifications during the bidding process.
    52.225-6 TRADE AGREEMENTS CERTIFICATE.docx
    The Trade Agreements Certificate (FAR 52.225-6) outlines the requirements for offerors regarding the origin of end products in federal contracts. It mandates that offerors certify that all products, except those noted as exceptions, are either U.S.-made or from designated countries. Offerors must list any products that are neither of these as "other end products," including their country of origin. The Government evaluates proposals based on federal acquisition regulations and will prioritize offers for U.S.-made or designated country products, disregarding Buy American restrictions for products covered by the World Trade Organization Government Procurement Agreement (WTO GPA). The Government only considers awards for qualified offers, ensuring compliance with the relevant procurement statutes to fulfill solicitation requirements. This provision is essential in ensuring that federal procurements support domestic and designated country manufacturing within trade agreement frameworks.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0111.xlsx
    The document outlines a Request for Quotation (RFQ) from the Department of Veterans Affairs (VA) for supplying Sumatrite 6mg/0.5ml injection syringes. Key information includes the estimated issuance and closing dates (01/07/25 and 01/14/25, respectively), award date (01/17/25), and delivery timeline (10 days after receipt of order). Suppliers must comply with the Drug Supply Chain Security Act (DSCSA), providing necessary documentation, including state wholesale distributor licenses, to verify compliance. The document specifies the required submission format for quoted prices and supporting documents, including a signed solicitation cover page, price schedule, and trade agreements certificate. It emphasizes the importance of adherence to DSCSA provisions, with detailed contact information for various VA CMOP (Contract Management Office Product) locations for submission. This RFQ reflects the VA’s ongoing efforts to ensure compliance and efficiency in obtaining critical medical supplies.
    Similar Opportunities
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0109 770-25-2-801-0180 -National CMOP SEVELAMER CARBONATE 800MG
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to fulfill an emergency procurement of Sevelamer Carbonate 800mg tablets for delivery to multiple CMOP facilities. The solicitation requires vendors to provide detailed quotes in Excel format, including compliance with the Drug Supply Chain Security Act and adherence to the Buy American statute, which emphasizes the preference for U.S.-made products. This procurement is critical for ensuring the availability of essential pharmaceuticals to support the healthcare needs of veterans. Interested vendors must submit their quotes by January 13, 2025, with the anticipated award date set for January 16, 2025; for further inquiries, contact Michael W McAlhaney at Michael.McAlhaney@va.gov or call (913) 684-0134.
    6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Fexofenadine HCL 60MG (500CT) for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). Vendors are required to submit detailed quotes that include a signed SF1449 solicitation cover page, a completed pricing schedule, a valid wholesale distributor license, and OEM authorization for over-the-counter products, ensuring compliance with the Buy American Act and other regulatory standards. This pharmaceutical product is critical for treating allergies and must meet stringent quality and safety requirements, including a minimum shelf life of one year upon delivery. Proposals are due by January 10, 2025, at 3:00 PM CT, and interested vendors can contact Contract Specialist Jennifer D Coleman at jennifer.coleman4@va.gov for further information.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0051 762-25-1-040-0048 -Tucson CMOP FEXOFENADINE HCL -(VA-25-00013424)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Fexofenadine HCL 180mg tablets for delivery to the Tucson CMOP facility. This procurement requires compliance with the Drug Supply Chain Security Act (DSCSA) and mandates that vendors submit specific documentation, including a signed SF-1449 cover page, a completed price schedule in Excel format, and proof of state wholesale distributor licensure. The pharmaceuticals are critical for ensuring the health and well-being of veterans, reflecting the government's commitment to providing quality medical supplies. Interested vendors must submit their quotes by January 10, 2025, with an estimated award date of January 13, 2025; for further inquiries, contact Jeffrey A. Blackard at jeffrey.blackard@va.gov or call (913) 684-0142.
    6505--761-25-1-015-0002 -Chelmsford CMOP 7 PHARMACEUTICALS (VA-25-00012193)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to supply thirteen specific pharmaceuticals for delivery to the Chelmsford Consolidated Mail Outpatient Pharmacy (CMOP) in Massachusetts. The procurement includes items such as Clomiphene Citrate and various Amlodipine/Benzapril combinations, with strict requirements for compliance with the Drug Supply Chain Security Act and a minimum one-year shelf life upon delivery. This initiative is crucial for maintaining an adequate pharmaceutical inventory to support the healthcare needs of veterans. Interested vendors must submit their proposals by December 2, 2024, including a signed SF1449 form, a completed pricing schedule, proof of a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, directed to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov.
    6505--761-25-1-015-0001 -Chelmsford CMOP Pharm -(VA-25-00012051)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Quotation (RFQ) for various pharmaceutical products to be supplied to the Chelmsford VA Center facility. The procurement includes items such as a vaginal gel, multivitamin tablets, and a wound therapy solution, with specific quantities and packaging requirements outlined for each product. This solicitation underscores the VA's commitment to ensuring a stable supply of essential medications for veterans while adhering to federal procurement regulations. Interested vendors must submit their quotations by January 17, 2025, and provide necessary documentation, including a state wholesale distributor license and OEM authorization, to the designated contract specialist, Lacie Nowak, at Lacie.nowak@va.gov.
    Rizatriptan Benzoate
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rizatriptan Benzoate tablets. The contract will establish a national supply source to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The solicitation will be posted on the DLA Bid Board System and SAM.gov. Interested parties should contact Keith Ryales for any questions/comments. The projected solicitation date is June 2022.
    6505--765-25-1-021-0009 -Hines CMOP ACAMPROSATE -(VA-25-00012693)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of Acamprosate Calcium 333mg, specifically for the Hines Consolidated Mail Outpatient Pharmacy (CMOP). This solicitation, identified by requisition number 36C77025Q0022, requires vendors to comply with federal regulations, including adherence to the Buy American Act, and mandates that all products have a minimum expiration date of one year upon delivery. The procurement is critical for ensuring reliable access to essential pharmaceuticals for veterans, emphasizing quality assurance and regulatory compliance throughout the process. Interested vendors must submit their quotes by January 10, 2025, at 3:00 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov or by phone at 913-758-9934.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to supply Cyclobenzaprine HCL Tablets under solicitation number VA-25-00015093. The procurement involves providing pharmaceutical supplies over a base year and four option years, with specific requirements for submission formats, safety protocols, and compliance with drug supply chain security standards. Cyclobenzaprine is a critical medication used for muscle relaxation, making this procurement essential for ensuring consistent availability for veterans and healthcare facilities. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details regarding the submission process and compliance requirements.
    6505--Tamsulosin Capsules
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--Baclofen Tablets (VA-25-00026620)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) 36E79725R0015 for the procurement of Baclofen Tablets, aimed at ensuring a reliable supply for various federal health facilities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The procurement will cover a one-year contract with four additional pre-priced option years, requiring offerors to provide products labeled with their unique National Drug Code (NDC) numbers. This initiative is critical for maintaining uninterrupted access to essential medications for veterans and other federal health service users. Interested suppliers should note that the solicitation will be electronically posted on or around December 30, 2024, with a submission deadline of January 13, 2025; inquiries can be directed to Contract Specialist Adrienne A. Albachiara at adrienne.albachiara@va.gov.